Dominique Genet

1.9k total citations
41 papers, 889 citations indexed

About

Dominique Genet is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Dominique Genet has authored 41 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Dominique Genet's work include Cancer Treatment and Pharmacology (19 papers), Colorectal Cancer Treatments and Studies (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Dominique Genet is often cited by papers focused on Cancer Treatment and Pharmacology (19 papers), Colorectal Cancer Treatments and Studies (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Dominique Genet collaborates with scholars based in France, Belgium and Italy. Dominique Genet's co-authors include Sylvie Giacchetti, Françis Lévi, C. Focan, Marco Tampellini, Georg A. Bjarnason, Carlo Garufi, N. Tubiana-Mathieu, Bruno Coudert, Thierry Gorlia and M.A. Lentz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Dominique Genet

40 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dominique Genet France	14	422	259	226	146	92	41	889
Jean-Michel Vannetzel France	14	715 1.7×	172 0.7×	383 1.7×	97 0.7×	160 1.7×	28	1.4k
Mohamed Bouchahda France	17	496 1.2×	230 0.9×	169 0.7×	136 0.9×	57 0.6×	43	801
G Gardani Italy	20	660 1.6×	136 0.5×	499 2.2×	73 0.5×	233 2.5×	67	1.7k
Susan B. Brown United States	8	322 0.8×	128 0.5×	217 1.0×	86 0.6×	175 1.9×	10	893
Benoît Baron France	16	696 1.6×	290 1.1×	1.4k 6.2×	159 1.1×	227 2.5×	24	2.1k
Christian Focan Belgium	8	323 0.8×	103 0.4×	130 0.6×	57 0.4×	48 0.5×	10	535
Ioannis Gkiozos Greece	16	376 0.9×	24 0.1×	348 1.5×	157 1.1×	213 2.3×	63	887
Michelle Shayne United States	19	774 1.8×	28 0.1×	293 1.3×	159 1.1×	268 2.9×	44	1.4k
Roberto Salgado Belgium	13	893 2.1×	37 0.1×	215 1.0×	68 0.5×	504 5.5×	35	1.5k
Elena Piazza Italy	14	702 1.7×	57 0.2×	408 1.8×	175 1.2×	117 1.3×	31	1.3k

Countries citing papers authored by Dominique Genet

Since Specialization

Citations

This map shows the geographic impact of Dominique Genet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominique Genet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominique Genet more than expected).

Fields of papers citing papers by Dominique Genet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominique Genet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominique Genet. The network helps show where Dominique Genet may publish in the future.

Co-authorship network of co-authors of Dominique Genet

This figure shows the co-authorship network connecting the top 25 collaborators of Dominique Genet. A scholar is included among the top collaborators of Dominique Genet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominique Genet. Dominique Genet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rouge, Thibault De La Motte, Jean‐Sébastien Frenel, Barbara Pistilli, et al.. (2022). 167MO Association between ER, PR and HER2 levels and outcome under palbociclib (Pal) + aromatase inhibitors (AIs) as first-line therapy for ER+ HER2- metastatic breast cancer (MBC): An exploratory analysis of the PADA-1 trial. Annals of Oncology. 33. S200–S200. 3 indexed citations

Boige, Valérie, Éric François, Méher Ben Abdelghani, et al.. (2021). 429P Maintenance treatment with cetuximab versus observation in RAS wild-type metastatic colorectal cancer: First results of the randomized phase II TIME-PRODIGE28 UNICANCER study according to RAS/BRAF status. Annals of Oncology. 32. S548–S549. 1 indexed citations

Boige, Valérie, Éric François, Méher Ben Abdelghani, et al.. (2021). Maintenance treatment with cetuximab versus observation in RAS wild-type metastatic colorectal cancer: Results of the randomized phase II PRODIGE 28-time UNICANCER study.. Journal of Clinical Oncology. 39(3_suppl). 15–15. 8 indexed citations

Perrier, Hervé, Marine Lefèvre, Christophe Louvet, et al.. (2020). Drastic Reduction of Turnaround Time After Implementation of a Fully Automated Assay for RAS-BRAF Mutations in Colorectal Cancer: A Pilot Prospective Study in Real-life Conditions. Pathology & Oncology Research. 26(4). 2469–2473. 2 indexed citations

Heudel, Pierre-Étienne, Maryam Karimi, Cari Levy, et al.. (2020). 1710P International multicentric evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits (TV) during the COVID-19 outbreak. Annals of Oncology. 31. S1006–S1006. 1 indexed citations

Aparicio, Thomas, Olivier Bouché, Julien Taı̈eb, et al.. (2017). Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results. Annals of Oncology. 29(1). 133–138. 50 indexed citations

Aparicio, Thomas, O. Bouché, Éric François, et al.. (2016). Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20. Annals of Oncology. 27. vi194–vi194. 1 indexed citations

Aparicio, Thomas, Olivier Bouché, Éric François, et al.. (2015). PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial.. Journal of Clinical Oncology. 33(15_suppl). 3541–3541. 6 indexed citations

Quoix, Élisabeth, John Nemunaitis, Zsolt Pápai, et al.. (2015). TG4010 Immunotherapy Combined with First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC). Phase 2B Results of the Time Study. Annals of Oncology. 26. i29–i29. 1 indexed citations

10.

Lavau‐Denès, Sandrine, Philippe Lacroix, A. Maubon, et al.. (2013). Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Cancer Chemotherapy and Pharmacology. 72(1). 65–73. 53 indexed citations

11.

Lavau‐Denès, Sandrine, Philippe Lacroix, A. Maubon, et al.. (2012). Prophylaxis of Catheter-Related Deep Vein Thrombosis in Cancer Patients with Low-Dose Warfarin, Low Molecular Weight Heparin, or Control: A Randomized, Controlled, Phase III Study. Annals of Oncology. 23. ixe29–ixe29. 1 indexed citations

12.

Brun-Ly, Valérie Le, Laurence Venat‐Bouvet, Nicole Darodes, et al.. (2009). Cardiac Toxicity with Capecitabine, Vinorelbine and Trastuzumab Therapy: Case Report and Review of Fluoropyrimidine-Related Cardiotoxicity. Oncology. 76(5). 322–325. 7 indexed citations

13.

Innominato, Pasquale F., C. Focan, Thierry Gorlia, et al.. (2009). Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer. Cancer Research. 69(11). 4700–4707. 184 indexed citations

14.

Genet, Dominique, et al.. (2008). Métastase surranélienne : survie après chirurgie d’exérèse. Journal de Chirurgie. 145(4). 346–349. 4 indexed citations

15.

Coudert, Bruno, Christian Focan, Dominique Genet, et al.. (2008). A Randomized Multicenter Study of Optimal Circadian Time of Vinorelbine Combined with Chronomodulated 5‐Fluorouracil in Pretreated Metastatic Breast Cancer Patients: EORTC Trial 05971. Chronobiology International. 25(5). 680–696. 20 indexed citations

16.

Priou, Franck, Alain Zannetti, Alain Ravaud, et al.. (2007). Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer. Annals of Oncology. 18(6). 1064–1070. 42 indexed citations

17.

Giacchetti, Sylvie, Georg A. Bjarnason, Carlo Garufi, et al.. (2006). Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group. Journal of Clinical Oncology. 24(22). 3562–3569. 178 indexed citations

18.

Genet, Dominique, Didier Cupissol, G. Calais, et al.. (2004). Docetaxel Plus 5-Fluorouracil in Locally Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck. American Journal of Clinical Oncology. 27(5). 472–476. 19 indexed citations

19.

Aubard, Y., et al.. (2003). Prise en charge du cancer du col utérin au stade IB. Proposition d'un protocole fondé sur une revue de la littérature. Gynécologie Obstétrique & Fertilité. 31(1). 2–13. 5 indexed citations

20.

Sauvage, François‐Ludovic, Annick Rousseau, Dominique Genet, et al.. (2001). Sensitive determination of vinorelbine and its metabolites in human serum using liquid chromatography-electrospray mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 753(2). 167–178. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact